Scharen-Guivel Hilda Frederique

SEC Form 4 insider trading activity

Scharen-Guivel Hilda Frederique has filed 4 SEC Form 4 filings (5 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Jun 4, 2026.

On the most recent filing, Scharen-Guivel Hilda Frederique is listed as Director at IRADIMED CORP. Inside the rolling window, Scharen-Guivel Hilda Frederique reported no open-market purchases and 1 open-market sale totaling $285K in IRMD.

Companies traded

Other insiders at IRMD

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$285K

reported sales (SEC code S)

Companies

1

in the rolling window

Source
IRMD
Scharen-Guivel Hilda Frederique
Sale$285KJun 4SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Scharen-Guivel Hilda Frederique made?

Scharen-Guivel Hilda Frederique has filed 4 SEC Form 4 filings (5 transaction rows) across 1 company since 2025.

Which companies does Scharen-Guivel Hilda Frederique trade?

Scharen-Guivel Hilda Frederique has filed SEC Form 4 disclosures for 1 company, including IRMD.

When was Scharen-Guivel Hilda Frederique's most recent SEC Form 4 filing?

Scharen-Guivel Hilda Frederique's most recent SEC Form 4 filing on Tracefour is dated Jun 4, 2026.

What is Scharen-Guivel Hilda Frederique's total buy and sell value in the current window?

Inside the rolling retention window, Scharen-Guivel Hilda Frederique bought $0 and sold $285K based on SEC Form 4 filings.

What was Scharen-Guivel Hilda Frederique's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 3,000 IRMD shares on 2026-06-04, worth $285K, per SEC Form 4 filings.